Tandem Diabetes Care (TNDM) News Today

$47.30
+0.37 (+0.79%)
(As of 05/17/2024 ET)
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Position Reduced by Jump Financial LLC
Jump Financial LLC trimmed its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 80.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,100 shares of the medical device company's stock after selli
Natixis Advisors L.P. Purchases Shares of 34,681 Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Natixis Advisors L.P. acquired a new position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 34,681 shares of the medica
M&T Bank Corp Purchases 26,943 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
M&T Bank Corp raised its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 118.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 49,649 shares of the medical device company's stock after ac
Truist Financial Corp Takes $2.59 Million Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Truist Financial Corp acquired a new stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 87,484 shares of the medical device company's stock, valued at approximately $2,588,000. Truist Financi
Russell Investments Group Ltd. Purchases 109,505 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Russell Investments Group Ltd. increased its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 79.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 247,325 shares of the medical device
Tandem Diabetes Care (NASDAQ:TNDM) PT Raised to $55.00
Lisanti Capital Growth LLC Invests $3.13 Million in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Lisanti Capital Growth LLC purchased a new position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 105,895 shares o
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $55.00 by Analysts at Barclays
Barclays lifted their target price on shares of Tandem Diabetes Care from $39.00 to $55.00 and gave the company an "overweight" rating in a research note on Monday.
Tandem Diabetes Care (NASDAQ:TNDM) Sets New 12-Month High After Analyst Upgrade
Tandem Diabetes Care (NASDAQ:TNDM) Hits New 12-Month High Following Analyst Upgrade
Tandem Diabetes Care (NASDAQ:TNDM) Earns "Overweight" Rating from Piper Sandler
Piper Sandler reiterated an "overweight" rating and set a $50.00 price target (up previously from $35.00) on shares of Tandem Diabetes Care in a report on Friday.
Tandem Diabetes Care (NASDAQ:TNDM) PT Raised to $36.00
Robert W. Baird increased their price objective on shares of Tandem Diabetes Care from $28.00 to $36.00 and gave the stock a "neutral" rating in a report on Friday.
Q1 2024 Tandem Diabetes Care Inc Earnings Call
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up to $35.24
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up to $35.24
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded to Overweight at Wells Fargo & Company
Wells Fargo & Company raised shares of Tandem Diabetes Care from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $21.00 to $45.00 in a report on Monday.
Tandem Diabetes Care (NASDAQ:TNDM) Lifted to Outperform at Leerink Partnrs
Leerink Partnrs raised shares of Tandem Diabetes Care from a "market perform" rating to an "outperform" rating in a research note on Thursday.
Jennison Associates LLC Has $38.18 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jennison Associates LLC grew its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 14.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,290,590 shares of the medical device company's stock after acquiring an additional 167,675 shares du
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded to "Outperform" by SVB Leerink
SVB Leerink upgraded Tandem Diabetes Care from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $34.00 to $45.00 in a research report on Thursday.
Tandem Diabetes Care Inc
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $40.00 by Analysts at Stifel Nicolaus
Stifel Nicolaus increased their price target on shares of Tandem Diabetes Care from $37.00 to $40.00 and gave the company a "buy" rating in a research report on Tuesday.
Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 7.9%
Tandem Diabetes Care (NASDAQ:TNDM) Trading 7.9% Higher
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. trimmed its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 15.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 130,858 shares of the
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 2.9%
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 2.9%
Raymond James & Associates Purchases 51,721 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Raymond James & Associates grew its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 128.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 91,985 shares of the medical device company's
Tandem Diabetes Care (NASDAQ:TNDM) Downgraded by StockNews.com to Sell
StockNews.com lowered Tandem Diabetes Care from a "hold" rating to a "sell" rating in a research note on Thursday.
Should You Invest in Tandem Diabetes Care (TNDM)?
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $38.00
Citigroup lifted their price target on Tandem Diabetes Care from $31.00 to $38.00 and gave the stock a "neutral" rating in a research report on Wednesday.
Chicago Capital LLC Has $14.11 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Chicago Capital LLC reduced its stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 47.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 476,937 shares of the medical device company's stock afte
Tandem Diabetes Care (NASDAQ:TNDM) Shares Down 6.1%
Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 6.1%
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Rating of "Hold" from Brokerages
Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Get Free Report) has been given a consensus rating of "Hold" by the twelve analysts that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation an
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Short Interest Update
Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 8,080,000 shares, an increase of 64.9% from the February 29th total of 4,900,000 shares. Based on an average daily trading volume, of 1,800,000 shares, the days-to-cover ratio is currently 4.5 days.
Get Tandem Diabetes Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

Elon to Transform U.S. Economy? (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

TNDM Media Mentions By Week

TNDM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TNDM
News Sentiment

1.14

0.50

Average
Medical
News Sentiment

TNDM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TNDM Articles
This Week

4

5

TNDM Articles
Average Week

Get Tandem Diabetes Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TNDM) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners